|
RPN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.317800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.652400E-01 |
| Normal-vs-Stage2 |
2.129800E-01 |
| Normal-vs-Stage3 |
1.095210E-01 |
| Normal-vs-Stage4 |
2.878600E-01 |
| Stage1-vs-Stage2 |
1.546820E-01 |
| Stage1-vs-Stage3 |
2.928100E-02 |
| Stage1-vs-Stage4 |
2.039000E-01 |
| Stage2-vs-Stage3 |
1.062060E-02 |
| Stage2-vs-Stage4 |
4.654300E-02 |
| Stage3-vs-Stage4 |
8.533800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.664000E-01 |
| Normal-vs-AfricanAmerican |
8.375800E-01 |
| Normal-vs-Asian |
3.008400E-01 |
| Caucasian-vs-AfricanAmerican |
9.823600E-01 |
| Caucasian-vs-Asian |
3.265800E-01 |
| AfricanAmerican-vs-Asian |
5.513200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.305200E-01 |
| Normal-vs-Female |
8.559400E-01 |
| Male-vs-Female |
5.154600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.789400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.364200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.797400E-01 |
| Normal-vs-Age(81-100Yrs) |
8.333400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.090000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.278600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.423800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.596400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.301800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.804400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.07889999945554E-07 |
| Classical-VS-Follicular |
4.119600E-01 |
| Classical-VS-Other |
7.715900E-02 |
| Classical-VS-Normal |
9.381400E-01 |
| Tall-VS-Follicular |
2.11569999999384E-05 |
| Tall-VS-Other |
8.720600E-01 |
| Tall-VS-Normal |
8.36600000000409E-05 |
| Follicular-VS-Other |
9.475700E-02 |
| Follicular-VS-Normal |
5.334000E-01 |
| Other-VS-Normal |
4.031600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.635400E-01 |
| Normal-vs-N1 |
1.959850E-02 |
| N0-vs-N1 |
3.964900E-03 |
|
|
